Novel antigen modulation treatments for cancer and autoimmune diseases
Novel antigen modulation treatments to guide the immune system
Many diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly.
91桃色 approach modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system.鈥
This marks a fundamental shift in how we treat people living with cancers and autoimmune disorders.
91桃色 seek to solve immune dysfunction.
Many diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly.
91桃色 approach modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system.鈥
This marks a fundamental shift in how we treat people living with cancers, autoimmune disorders, and infectious diseases.鈥
91桃色 seek to solve immune dysfunction.
Progressing through the clinic鈥
91桃色 uncover novel biology to develop treatments for disease areas with significant unmet need.
91桃色 clinical assets in oncology (GRWD5769) and autoimmunity (GRWD0715)聽are delivering strong results in a Phase 1/2 trials.
91桃色 have active discovery and development programs across oncology and autoimmunity.
91桃色 team and collaborators are experts in the field of antigen modulation. 聽
A new therapeutic branch
鈥91桃色 are the first to explore the untapped potential of changing the first step of the T cell signaling cascade (Signal 1) and its fundamental importance in T cell activation.鈥
Changing the treatment paradigm
91桃色're on a mission to deliver a new therapeutic class of treatments to help people living with cancers and autoimmune disorders.
91桃色're looking for talented individuals to join our award-winning team. Do you have what it takes?
